0001737287-18-000001.txt : 20180419 0001737287-18-000001.hdr.sgml : 20180419 20180419120256 ACCESSION NUMBER: 0001737287-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180419 DATE AS OF CHANGE: 20180419 EFFECTIVENESS DATE: 20180419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-310557 FILM NUMBER: 18762914 BUSINESS ADDRESS: STREET 1: 689 5TH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-871-7920 MAIL ADDRESS: STREET 1: 689 5TH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0708 D LIVE 0001737287 Allogene Therapeutics, Inc. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 (212) 871-7920 DELAWARE None None Corporation true 2017 JOSHUA A. KAZAM C/O ALLOGENE THERAPEUTICS, INC. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Executive Officer Director DAVID M. TANEN C/O ALLOGENE THERAPEUTICS, INC. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Executive Officer ARIE BELLDEGRUN C/O ALLOGENE THERAPEUTICS, INC. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director DAVID BONDERMAN C/O ALLOGENE THERAPEUTICS, INC. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director DAVID CHANG C/O ALLOGENE THERAPEUTICS, INC. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director ROBERT ABRAHAM C/O ALLOGENE THERAPEUTICS, INC. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director JOHN DEYOUNG C/O ALLOGENE THERAPEUTICS, INC. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director FRANZ HUMER C/O ALLOGENE THERAPEUTICS, INC. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director TODD SISITSKY C/O ALLOGENE THERAPEUTICS, INC. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director OWEN WITTE C/O ALLOGENE THERAPEUTICS, INC. 270 LITTLEFIELD AVE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2018-04-06 false true false 0 411770409 411770409 0 The consideration for $111,770,405 of the total offering amount was non-cash consideration, and the consideration for $150,000,002 of the total offering amount was capital commitments. false 23 0 0 0 false Allogene Therapeutics, Inc. /s/ David M. Tanen David M. Tanen Secretary 2018-04-19